- Home
- RVSB vs MAIA Comparison
RVSB vs MAIA Comparison
Compare RVSB & MAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVSB
- MAIA
- Stock Information
- Founded
- RVSB 1923
- MAIA 2018
- Country
- RVSB United States
- MAIA United States
- Employees
- RVSB N/A
- MAIA N/A
- Industry
- RVSB Savings Institutions
- MAIA Biotechnology: Pharmaceutical Preparations
- Sector
- RVSB Finance
- MAIA Health Care
- Exchange
- RVSB Nasdaq
- MAIA Nasdaq
- Market Cap
- RVSB 99.6M
- MAIA 62.4M
- IPO Year
- RVSB 1993
- MAIA 2022
- Fundamental
- Price
- RVSB $4.74
- MAIA $2.82
- Analyst Decision
- RVSB
- MAIA
- Analyst Count
- RVSB 0
- MAIA 0
- Target Price
- RVSB N/A
- MAIA N/A
- AVG Volume (30 Days)
- RVSB 17.9K
- MAIA 60.0K
- Earning Date
- RVSB 10-24-2024
- MAIA 11-05-2024
- Dividend Yield
- RVSB 1.70%
- MAIA N/A
- EPS Growth
- RVSB N/A
- MAIA N/A
- EPS
- RVSB 0.05
- MAIA N/A
- Revenue
- RVSB $46,297,000.00
- MAIA N/A
- Revenue This Year
- RVSB N/A
- MAIA N/A
- Revenue Next Year
- RVSB $12.93
- MAIA N/A
- P/E Ratio
- RVSB $98.52
- MAIA N/A
- Revenue Growth
- RVSB N/A
- MAIA N/A
- 52 Week Low
- RVSB $3.30
- MAIA $0.82
- 52 Week High
- RVSB $6.57
- MAIA $5.99
- Technical
- Relative Strength Index (RSI)
- RVSB 51.94
- MAIA 50.98
- Support Level
- RVSB $4.45
- MAIA $2.36
- Resistance Level
- RVSB $4.72
- MAIA $2.72
- Average True Range (ATR)
- RVSB 0.12
- MAIA 0.22
- MACD
- RVSB -0.00
- MAIA 0.02
- Stochastic Oscillator
- RVSB 61.43
- MAIA 72.28
About RVSB Riverview Bancorp Inc
Riverview Bancorp Inc is an American savings and loan holding company. The company through its subsidiaries engages in the business of attracting deposits and puts it to use in its market area to originate commercial business. It is organized into two operating segments, Banking Operations performed by the bank and trust and Investment Services performed by the Trust company. The company products and services include checking, saving, money market, mortgage, home equity, consumer, online banking, cash management, and others.
About MAIA MAIA Biotechnology Inc.
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company. The company develops targeted immunotherapies for cancer. The company is an immune-oncology company, focused on the development of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. The company's program is THIO, a potential cancer telomere-targeting agent in clinical development for the treatment of telomerase-positive cancer cells.